84 related articles for article (PubMed ID: 339536)
1. [Results of using dibunol in bladder tumors].
Barsel' VA; Dul'kin LM; Demidov AT
Vopr Onkol; 1977; 23(11):50-6. PubMed ID: 339536
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacodynamics of dibunol in the blood of patients with bladder neoplasms following oral and intravesical administration].
Barsel' VA; Matveeva SA
Izv Akad Nauk SSSR Biol; 1977; (2):258-63. PubMed ID: 886064
[No Abstract] [Full Text] [Related]
3. [Dibunol and thio-TEPA treatment of bladder tumors].
Barsel' VA
Urol Nefrol (Mosk); 1978; (4):27-30. PubMed ID: 98889
[No Abstract] [Full Text] [Related]
4. [Prevention of lymphogenic metastasis in the surgical treatment of rectal cancer].
Fedorov VD; Brusilovskiĭ MI; Eropkin PV; Odariuk TS; Maksimova LV
Vopr Onkol; 1980; 26(2):25-30. PubMed ID: 7361491
[TBL] [Abstract][Full Text] [Related]
5. Probability model of dibunol pharmakinetics.
Matveeva SA; Maksimov VM; Marshak YaI ; Konradov AA; Barsel' VA
Biol Bull Acad Sci USSR; 1979; 6(2):226-36. PubMed ID: 549670
[TBL] [Abstract][Full Text] [Related]
6. [Use of dibunol in radiotherapy of bladder tumors].
Dunchik VN; Barsel' VA; Sumskoĭ BS; Mardynskiĭ IuS
Med Radiol (Mosk); 1977 Dec; 22(12):13-6. PubMed ID: 414044
[No Abstract] [Full Text] [Related]
7. [Short-term versus long-term chemoprevention of recurrence with Epodyl following transurethral resection of superficial urinary bladder cancer].
Flamm J; Kühnel W; Dona S
Urologe A; 1989 Mar; 28(2):99-102. PubMed ID: 2655259
[TBL] [Abstract][Full Text] [Related]
8. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
Hendricksen K; Gleason D; Young JM; Saltzstein D; Gershman A; Lerner S; Witjes JA
J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407
[TBL] [Abstract][Full Text] [Related]
9. [Surgical treatment of rectal neoplasms in combination with preoperative endolymphatic therapy using dibunol solution].
Eropkin PV
Khirurgiia (Mosk); 1980 Aug; (8):74-9. PubMed ID: 7265732
[No Abstract] [Full Text] [Related]
10. Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).
de Reijke TM; Kurth KH; Sylvester RJ; Hall RR; Brausi M; van de Beek K; Landsoght KE; Carpentier P;
J Urol; 2005 Feb; 173(2):405-9. PubMed ID: 15643181
[TBL] [Abstract][Full Text] [Related]
11. Intravesical chemotherapy for superficial bladder tumors category Ta/T1: who should be treated and how?
Kurth KH
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):30-5. PubMed ID: 8727808
[TBL] [Abstract][Full Text] [Related]
12. [The antistressor action of dibunol in surgical stress in lung cancer patients].
Baraboĭ VA; Bororov LV; Gunina LM; Maevskaia LP
Eksp Klin Farmakol; 1994; 57(5):43-5. PubMed ID: 7696906
[TBL] [Abstract][Full Text] [Related]
13. [Use of dibunol in the complex treatment of tuberculosis of the bladder].
Nachankar RK; Mochalova TP; Solov'eva IP; Boĭkov AK; Barsel' VA
Urol Nefrol (Mosk); 1986; (5):39-42. PubMed ID: 3538599
[No Abstract] [Full Text] [Related]
14. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
[TBL] [Abstract][Full Text] [Related]
15. Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response.
van der Heijden AG; Moonen PM; Cornel EB; Vergunst H; de Reijke TM; van Boven E; Barten EJ; Puri R; van Kalken CK; Witjes JA
J Urol; 2006 Oct; 176(4 Pt 1):1349-53; discussion 1353. PubMed ID: 16952629
[TBL] [Abstract][Full Text] [Related]
16. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
[TBL] [Abstract][Full Text] [Related]
17. The immunomodulating effect of interferon-gamma intravesical instillations in preventing bladder cancer recurrence.
Giannopoulos A; Constantinides C; Fokaeas E; Stravodimos C; Giannopoulou M; Kyroudi A; Gounaris A
Clin Cancer Res; 2003 Nov; 9(15):5550-8. PubMed ID: 14654535
[TBL] [Abstract][Full Text] [Related]
18. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
19. Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?
Weiss C; Wolze C; Engehausen DG; Ott OJ; Krause FS; Schrott KM; Dunst J; Sauer R; Rödel C
J Clin Oncol; 2006 May; 24(15):2318-24. PubMed ID: 16710030
[TBL] [Abstract][Full Text] [Related]
20. Intravesical therapy for bladder cancer.
Soloway MS
Urol Clin North Am; 1988 Nov; 15(4):661-9. PubMed ID: 3142129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
